PAX3 and neoplasm: Expression levels were quantified relative to expression in the RD cell line (RDCL) for PAX3 and PAX7, the Rh30 cell line for PAX3-FKHR and a primary tumour (sample 6) for PAX7-FKHR, since no cell line expressing this fusion gene was available.